首页> 外文期刊>International Medical Case Reports Journal >Presymptomatic genetic analysis during pregnancy for vascular type Ehlers–Danlos syndrome
【24h】

Presymptomatic genetic analysis during pregnancy for vascular type Ehlers–Danlos syndrome

机译:血管型Ehlers–Danlos综合征妊娠前的症状前遗传学分析

获取原文
获取外文期刊封面目录资料

摘要

Abstract: The vascular type of Ehlers–Danlos syndrome (EDS), EDS type IV (Online Mendelian Inheritance in Man [MIM] #130050) is characterized by thin, translucent skin, easy bruising, and arterial, intestinal, and/or uterine fragility during pregnancy, which may lead to sudden death. It is an autosomal dominant inherited disorder caused by type III procollagen gene (COL3A1: MIM #120180) mutations. Approximately 50% of the COL3A1 mutations are inherited from an affected parent, and 50% are de novo mutations. Each child of an affected individual has a 50% chance of inheriting the mutation and developing the disorder. Pregnant women with vascular EDS are at an increased risk of uterine and arterial rupture during the peripartum period, with high maternal morbidity and mortality rates. We report the first case of an asymptomatic 35-year-old woman at a risk of complications of vascular EDS who underwent presymptomatic evaluation during pregnancy. The sequencing results of both her brother and mother had a one-base-pair deletion, resulting in Glutamate at position 730 changing to Lysine and causing a frame shift and premature termination codon at 61 amino acids from the mutation position (p. Glu730Lysfs*61) on exon 32 of COL3A1. This deletion caused frameshift, leading to a premature termination codon (TAG) at 181 nucleotides downstream in exon 35, which could not be detected by previous total RNA (ribonucleic acid) method. Thus, she was at risk of complications of vascular EDS, and diagnostic testing was employed at 8 weeks of pregnancy to minimize the risk of developing vascular EDS-related complications. The negative presymptomatic diagnostic result allowed the patient to choose normal delivery at term. Vascular EDS is a serious disorder, with high mortality, especially in high-risk women with vascular EDS during pregnancy. The presymptomatic genetic testing of vascular EDS during pregnancy for a high-risk family can help with the early establishment of preventive measures.
机译:摘要:Ehlers-Danlos综合征(EDS)的血管类型,IV型EDS(人类在线孟德尔遗传[MIM]#130050)的特征是皮肤稀薄,半透明,容易瘀伤以及动脉,肠和/或子宫脆弱。在怀孕期间,可能会导致猝死。它是由III型前胶原基因(COL3A1:MIM#120180)突变引起的常染色体显性遗传病。大约50%的COL3A1突变是从受影响的父母那里继承的,而50%是从头突变。患病个体的每个孩子都有50%的机会遗传突变并发展为疾病。患有血管EDS的孕妇在围产期子宫和动脉破裂的风险增加,孕产妇发病率和死亡率较高。我们报告了第一例无症状的35岁妇女,在妊娠期间接受症状前评估的情况下有血管EDS并发症的风险。她的兄弟和母亲的测序结果均具有一个碱基对的缺失,导致730位的谷氨酸变为赖氨酸,并导致突变位置和61个氨基酸处的移码和过早终止密码子(p。Glu730Lysfs * 61) )在COL3A1的第32外显子上。此删除导致移码,导致外显子35下游181个核苷酸处的提前终止密码子(TAG),以前的总RNA(核糖核酸)方法无法检测到该密码子。因此,她有发生血管性EDS并发症的风险,并且在妊娠8周时进行了诊断测试,以最大程度地降低发生血管性EDS相关并发症的风险。症状前的阴性诊断结果使患者可以选择足月分娩的正常分娩。血管EDS是一种严重的疾病,死亡率很高,尤其是在怀孕期间患有血管EDS的高危女性中。对于高危家庭,在妊娠期间对血管EDS进行症状前的基因检测可以帮助及早建立预防措施。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号